transitioning from tirzepatide to retatrutide vs for weight loss and body recomp Switching From Tirzepatide to Retatrutide

L., Kern, D

The Fueled Framework does not provide medical advice

These vendors may not have the decade-long track record of Category 1 companies, but they compensate by making third-party test results readily available, often posting them directly on product pages

The answer is yesbut with realistic expectations

However, lean body mass also decreased by 10.9% in the tirzepatide group versus 2.6% with placebo

Although retatrutide's glucose-dependent mechanism of action is designed to reduce hypoglycaemia risk compared with agents such as sulphonylureas or insulin, the risk is not eliminated particularly when retatrutide is used alongside other glucose-lowering therapies